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Abbreviation 
Abbreviation 
53BP1 tumor suppressor p53-binding protein 1 
ATM ataxia-telangiectasia mutated 
ATR ataxia-telangiectasia mutated and Rad3-related 
BLM Bloom syndrome protein 
BRCA1 breast cancer 1 susceptibility protein 
BRCA2 breast cancer 2 susceptibility protein 
BRCT BRCA1 C-terminal 
CHK checkpoint kinase 
DDR DNA damage response 
DNA-PK DNA-dependent protein kinase 
DNA-PKcs DNA-dependent protein kinase catalytic subunit 
DSB (DNA) double-strand break 
ERCC1 Excision repair cross-complementing protein 1 
H2AX phosphorylated histone H2AX 
HAT histone acetyltransferase 
HR homologous recombination 
HRS hyper-radiosensitivity 
hSSB1 human single-strand DNA-binding protein 1 
IRR increasing radioresistance 
LNT linear-no-threshold 
LigIV Ligase IV 
MDC1 mediator of DNA damage checkpoint 1 
Abbreviation 
MDM2 murine double minute 2 oncoprotein 
MRN Mre11-Rad50-Nbs1 complex 
NHEJ non-homologous end-joining 
PARP-1 Poly [ADP-ribose] polymerase 1  
PCNA proliferating cell nuclear antigen 
PIKKs phosphatidylinositol 3-kinase-related kinases 
RIF radiation-induced foci 
ROS reactive oxygen species 
RPA replication protein A 
SCID severe combined immunodeficiency 
SSB (DNA) single-strand break 
STAT1 Signal Transducer and Activators of Transcription factor 1 
TBP TATA-box-binding protein 
TEM transmission electron microscopy 
Tip60 Tat interacting protein of molecular weight 60kDa 
WRN Werner syndrome protein 
XLF XRCC4-like factor 
XRCC X-ray repair cross-complementing protein 
XPF Xeroderma pigmentosum group F-complementing protein 
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1. Abstract 
1.1 Purpose  
Health effects of low dose radiation continue to be a matter of debate for 
concerns of radiological estimate and protection. In this present study, we 
investigated the effects of fractionated low dose radiation exposure on 
accumulation of DSBs in normal tissues using an in vivo murine model. This 
in vivo model may help us to estimate the effects of exposure to environmental 
and occupational sources of low dose radiation among normal people and help 
us to assess the long-term effects of normal tissue irradiation in the context of 
fractionated radiotherapy. 
 
1.2 Materials and methods  
After whole body fractionated low dose irradiation of wild-type male 
C57BL/6 mice, the induction and repair of DSBs were analyzed in kidney and 
intestine by enumerating 53BP1 foci. 
 
1.3 Results 
A single acute low dose irradiation with 10 mGy or 100 mGy induced 
nearly the identical foci level in the kidney and the small intestine. Persistent 
foci levels at different time points varied slightly during fractionated 
irradiation with 10 mGy while slightly elevated, but consistent foci levels 
were observed during fractionated irradiation with 100 mGy in both kidney 
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and small intestine. The values of persistent foci in the tubular cells in kidney 
were always higher than those in the epithelial cells in intestine, independent 
of the dose per fraction, or analyzed time points. 
 
1.4 Conclusion 
A single acute low dose radiation has the same ability to induce DSBs in 
kidney and small intestine. Persistent foci levels in the tubular cells in kidney 
were always higher than those in the epithelial cells in the intestine, 
independent of the dose per fraction, or analyzed time points, which might 
indicate they have different ability to deal with complex DSBs and chromatin 
alterations induced by fractionated low dose irradiation. 
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2. Introduction 
Ionizing radiation (IR) is a ubiquitous environmental mutagen and a 
prototypical DNA-damaging agent. The effects of low-dose and low-dose-rate 
ionizing radiation continue to be of interest because of the potential dangers 
posed by exposure to environmental and occupational sources of radiation [1] 
and because of the potential clinical benefits of radiotherapy [2]. 
Epidemiological studies indicate that the cancer risk increases with IR 
exposure even at low doses [3-5], however some experimental evidences 
support that low-dose radiation increases cellular antioxidant activity [6], 
facilitates DNA damage repair [7], stimulates immune surveillances [8-10], 
and suppresses tumor growth, metastasis and carcinogenesis [10, 11]. Large 
uncertainties remain concerning in the relationship between the ionizing dose 
in the low dose range and the biological effects. 
Ionizing radiation induces a variety of DNA lesions, including single- and 
double-strand breaks, DNA-protein cross-links, and various base damages. 
Among all kinds of DNA damages, DNA double-strand breaks (DSBs) are the 
most closely related to the deleterious consequences. Based on data obtained 
from high-dose irradiation in vivo and in vitro, it is assumed that the induction 
of DSBs is dependent on the irradiation dose. Since direct evidence to prove 
the dose-response relationship of DSBs in the low dose range irradiation is 
very limited, the effect of low-dose radiation is usually estimated by an 
extrapolation from the high-dose range. However, the effect of 
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radiation-induced DSBs may be different in the high dose versus the low dose 
levels. Recent findings in radiation and molecular biology strongly challenge 
this extrapolation and several new conceptions have been proposed on the low 
dose irradiation. 
 
2.1 DNA double-strand break 
2.1.1 DNA damage response (DDR) 
A well accepted paradigm in radiation biology is that DNA double-strand 
break (DSB) is the most deleterious form of DNA damage, making serious 
threat to the integrity of eukaryotic genomes. DSBs can be induced by 
exposure to exogenous agents such as ionizing radiation (IR), external 
mutagens and chemotherapeutics, as well as endogenous agents such as 
reactive oxygen species (ROS). It can also arise from collapsed replication 
forks [12, 13] and the processes of V(D)J recombination and class switch 
recombination (CSR) in the development and maturation of immune system 
[14-16]. Unrepaired DSBs can lead to cell death while misrepaired DSBs have 
the potential to produce chromosomal translocations and genome instability, 
which can contribute to malignant transformations. To protect the integrity of 
the genome, cells have evolved efficient and rapid repair responses, a 
sophisticated signal transduction cascade, known as DNA damage response 
(DDR) which initiates processes such as cell-cycle arrest, DNA repair and 
apoptosis before DNA replication and cell division [17]. Numerous proteins 
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engage in this network and can be classified as DNA-damage sensors, 
mediators, transducers and effectors [18]. Sensors are thought to detect the 
presence of DNA damage. Although the nature of these sensors and the 
mechanisms of detection remain unclear, the earliest detectable DNA 
DSB-induced events involve the MRN [MRE11 (meiotic recombination 
11)-RAD50-NBS1 (Nijmegen breakage syndrome 1)] complex [19] and the 
PIKKs (phosphatidylinositol 3-kinase-related kinases) family such as ATM 
(ataxia-telangiectasia mutated) and ATR (ATM and RAD3-related) [20, 21]. 
From these proteins, the DNA damage signal is transmitted to transducer 
kinases such as CHK1 (checkpoint kinase 1) and CHK2 (checkpoint kinase 2), 
which target downstream DDR components, as well as amplifying the DDR 
signal [22]. The signaling between sensors and transducers is thought to be 
facilitated by mediators or adaptor proteins, such as MDC1 (mediator of DNA 
damage checkpoint 1), 53BP1 (p53-binding protein 1) and BRCA1 (breast 
cancer 1 susceptibility protein), which are believed to receive a structural 
modification by the sensor proteins and this modification is converted to a 
compatible form for signal amplification by the transducer proteins [23]. The 
activated sensor and transducer kinases proceed to phosphorylate a number of 
downstream effectors, resulting in appropriate biological responses depending 
on the severity of the damage and cell cycle status. Figure 1 shows the current 
model of the mammalian DNA damage response. 
Many proteins known to be involved in DNA damage repair or in signaling 
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the presence of DNA damage have been shown to localize to the sites of DSBs 
within seconds to minutes following ionizing radiation, resulting in the 
formation of microscopically visible nuclear domains referred to as 
radiation-induced foci (RIF). These proteins include -H2AX, ATM, 53BP1, 
MDC1, RAD51, and the MRN complex (MRE11/RAD50/NBS1). The RIF are 
dynamic structures and the analysis of these DNA damage related foci allow 
researchers to gain deeper insights into the effects of ionizing radiation. 
 
 
Figure 1: Current model of the mammalian DNA damage and replication checkpoints. A 
line ending with an arrowhead indicates activation. A line ending with a bar indicates 
inhibition. Figure was taken from Lei Li and Lee Zou, 2005 [24]. 
 
2.1.2 DSB repair pathways 
There are two major pathways for DSB repair, namely non-homologous 
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end-joining (NHEJ) and homologous recombination (HR). In mammalian 
cells, the majority of radiation-induced DSBs are repaired by NHEJ. NHEJ 
functions throughout the cell cycle and is the major pathway for the repair of 
DSBs that arise during G0 and G1 [25]. In addition, NHEJ is responsible for 
the repair of programmed DSBs generated during V(D)J recombination [14, 
16]. In contrast, HR functions preferentially in late S and G2 when an intact 
sister chromatid is available to act as a template for repair. HR can also use a 
homologous chromosome as a template and some HR is observed in G0/G1 
cells, albeit at a level lower than in S/G2/M phase [26]. One of the main 
functions of HR is to repair endogenous DSBs that are produced when 
replication forks collapse [27, 28]. 
 
2.1.2.1 Non-homologous end-joining 
Non-homologous end-joining (NHEJ) simply pieces together the broken 
ends and reseals them previously trimmed by various nucleases. The basic 
steps in NHEJ are (1) detection of the DSB and tethering of the DNA ends; (2) 
processing the DNA termini to remove non-contactable end groups; (3) 
religation of the processed DNA ends. Since DNA ends are joined with little 
or no base pairing at the junction and end joining can be accompanied by 
insertions or deletions, NHEJ is widely regarded as being error prone. Six core 
proteins are known to be required for NHEJ in mammalian cells: the Ku70/80 
heterodimer (KU), the catalytic subunit of the DNA-dependent protein kinase 
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(DNA-PKcs), XRCC4, DNA LigIV (Ligase IV), XLF (XRCC4-like factor, 
also called Cernunnos) and a DNA processing factor, Artemis [29-31]. 
Deletion or inactivation of any of these core NHEJ proteins induces radiation 
sensitivity as well as defects in DSB repair and V(D)J recombination [12].  
The first step in NHEJ is detection of the DSB by the KU heterodimer. 
The KU complex is conserved throughout evolution and has a high affinity to 
the ends of double-stranded DNA, with little or no DNA sequence specificity 
[30, 32]. It can be rapidly recruited to sites of DNA damage and independently 
of any other NHEJ or DSB repair proteins [33]. Once bound to the DSB, KU 
acts as a scaffold to which other NHEJ proteins are recruited. Cells lacking 
KU are radiosensitive and KU-deficient mice are immunodeficient due to 
defective V(D)J recombination as well as growth and telomere defects [34, 
35]. One of the first proteins shown to interact with KU is DNA-PKcs. 
DNA-PKcs, the product of the PRKDC gene, is a member of the PIKKs 
family of serine-threonine protein kinases, and like other PIKKs family 
members: ATM and ATR, DNA-PKcs phosphorylate its substrate primarily on 
serines or threonines. DNA-PKcs has very weak protein kinase activity which 
is stimulated 5-10 fold by its interaction with DNA-bound KU to form the 
DNA-dependent protein kinase complex, DNA-PK. After assembly of the 
DNA-PK complex, which tethers the DNA ends together protecting them 
from inappropriate end processing, DNA-PKcs undergoes 
autophosphorylation in trans, leading to dissociation of DNA-PKcs from the 
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DNA ends, which facilitates access of downstream factors to the ends of the 
DSB [30, 36]. Another role of DNA-PKcs is to recruit the end-processing 
factor Artemis to DSBs [37]. Artemis has 5’-3’exonuclease activity. In the 
presence of DNA-PKcs and ATP, Artemis displays endonuclease activity 
towards DNA hairpins and single stranded DNA flaps [38]. This nuclease 
activity is required for opening DNA hairpins formed at coding joints during 
V(D)J recombination. Once the DNA ends have been processed, they are 
ligated by the XRCC4-DNA LigIV complex. XRCC4 and DNA LigIV are 
required for both NHEJ and V(D)J recombination and mice lacking either 
protein die in uterus due to massive neuronal apoptosis [39, 40]. Figure 2 








Figure 2: Schematic  
illustration of the NHEJ 
process. Figure was taken 
from Markus Loebrich and 
Penny A. Jeggo, 2007 [41]. 
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2.1.2.2 Homologous recombination 
The second major pathway for the repair of DSBs is homologous 
recombination (HR). It is a slow process requiring homologous sequences in 
the form of sister chromatids, homologous chromosomes or DNA repeats as 
template. Various proteins are involved in this process including RAD51, 
RAD52, and RAD54 as well as RAD51 paralogues including XRCC2, 
XRCC3, RAD52B, RAD51C and RAD51D [42]. HR is activated primarily 
during late S and G2 phase of the cell cycle and considered to be a relatively 
error free repair pathway [28, 43-45]. 
As shown in Figure 3, the initial step in HR is detection of the DSB by the 
MRE11-RAD50-NBS1 complex (MRN), which is followed by 5’-3’ resection 
to produce a long ssDNA 3’ extension [28, 43-45]. The ssDNA binding 
protein RPA binds to the long 3’-ssDNA extension, which prevents premature 
strand invasion and then the RAD51 forms nucleoprotein complex on ssDNA 
tails coated by RPA to form a presynaptic filament. Multiple proteins, 
including RAD52, BRCA2 and the RAD51 paralogues (RAD51B, RAD51C, 
RAD51D, XRCC2 and XRCC3) are subsequently involved in the replacement 
of RPA by RAD51, and stabilization of the filament [44, 45]. After that, the 
3’-ssDNA strand acquires the ability to invade the homologous sequence to 
form an intermediate called a D loop, which named “strand invasion”. Then 
the 3’-DNA end is extended by a DNA polymerase, and a second DSB end is 
captured by annealing to the extended D loop. This leads to the formation of 
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one or more crossed strand structure termed Holliday junctions. Finally, the 
Holliday junctions are resolved to produce either crossover or non-crossover 
products, depending on which HR subpathway is utilized [28, 43-45]. Other 
proteins that have been implicated in these steps include RAD54, WRN, BLM, 
p53, XPF, ERCC1, DNA polymerases delta and epsilon, PCNA and DNA 










 Figure 3: Schematic illustration 
of homologous recombination. 




2.1.2.3 DSB repair pathway choice 
The utilization of either NHEJ or HR can be regulated by the nature of the 
DSB and by cell type and cell-cycle phase. NHEJ is efficient at rejoining 
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DNA ends with cohesive overhangs, but is less efficient for blunt ends or ends 
without cohesive overhangs, which can be left to HR [47, 48]. An elegant 
study analyzed the selective requirement for HR and NHEJ during nervous 
system development [49] by using mice carrying a germ line disruption of 
XRCC2 (HR defective) and ligaseIV (NHEJ defective), the two pathways of 
recombination were found to be spatiotemporally distinct: HR inactivation 
was crucial from the early steps of embryogenesis leading to abundant 
apoptosis, whereas defective NHEJ had deleterious consequences only at late 
developmental stages. Since the late stages of embryogenesis are 
characterized by massive differentiation, these results may imply that the HR 
pathway has an essential protective role against DSB-induced cytotoxicity in 
proliferating cells and become dispensable in post-mitotic cells where NHEJ 
is the pathway of election. On the other hand, there are multiple pathways that 
can detect and repair radiation-induced DSBs, how the various DSB repair 
pathways are coordinated are still poorly understood [50, 51]. What 
determines whether a given DSB is detected by KU (to initiate NHEJ) or 
MRN (to activate ATM and subsequently ATR) is unknown. Laser microbeam 
irradiation experiments reveal that KU and MRN are recruited to the same 
sites of DNA damage independently throughout the cell cycle but whether 
they compete for binding to the same DSB or bind to different DSBs is not 
known [33]. The chromatin structure in the vicinity of the break may have a 
major effect on DSB repair and pathway choice [52]. 
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2.1.3 Proteins involved in DSB repair 
2.1.3.1 ATM 
ATM is the product of the gene mutated in Ataxia-Telangiectasia (A-T), a 
debilitating genetic disorder characterized by progressive neurodegeneration, 
immune system dysfunction, hypersensitivity to ionizing radiation and a 
marked predisposition to cancer. Cells derived from A-T patients were found 
to exhibit chromosomal instability and extreme sensitivity to DSB-inducing 
agents including ionizing radiation, but no or little sensitivity to other forms of 
DNA damage. ATM is a large protein (3056 amino acid residuals) largely 
composed of HEAT repeats [53], which are predicted to form a superhelical 
structure with concave and convex faces. The C-terminal end of ATM is 
composed of the PIKK-family kinase domain and a region named the “FATC” 
motif. Another domain, termed FAT, is juxtaposed N-terminal to the kinase 
domain. Taken as a protein serine-threonine kinase, ATM is included in the 
PIKK family and sharing several features with other family members such as 
DNA-PKcs and ATR.  
In undamaged cells, ATM is in a dimeric (or multimeric) inactive form 
with kinase domain bound to an internal domain of a neighboring ATM 
molecule containing serine 1981 [54], present throughout the nucleus. 
Following radiation, the kinase domain of one ATM molecule phosphorylates 
serine 1981 of an interacting ATM molecule. This phosphorylation event does 
not directly regulate the activity of the kinase, but disrupts ATM oligomers 
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and allows accessibility of substrates to the ATM kinase domain. The 
phosphorylated ATM dissociates from the complex and localizes to the 
chromatin that surrounds the DSB [55, 56]. Actually, ATM is considered as a 
“hierarchical kinase”, capable of initiating many pathways simultaneously 
[57]. After recruitment to sites of DNA damage, ATM phosphorylates a 
number of substrates, including c-Abl, CHK-1, CHK-2, RPA, BRCA1, 
BRCA2, NF-kB/IkB alpha, -adaptin, hSSB1 and autophosphorylation of 
ATM itself [57], which in turn targets other proteins to induce cell cycle arrest 
or apoptosis and facilitate DNA repair. A complex web of interplay among 
these proteins enhances their retention at the DSB. The interaction of ATM 
with proteins such as BRCA1, NBS1 and CHK-2 suggests its key role in both 
NHEJ and HR. 
ATM kinase activation seems to be an initiating event in cellular response 
to ionizing radiation and is linked to other factors; principal among these is 
the MRN complex. Studies show that the MRN complex acts as a 
double-strand break sensor for ATM and recruits ATM to broken DNA 
molecules, which occurs via its interaction with the C-terminus of NBS1 [58], 
The ability of the MRN complex to tether broken DNA ends provides a 
scaffold for recruitment of critical signaling kinases such as ATM. Cells in 
which the MRN complex is compromised can affect ATM localization to 
DNA damage-induced foci or show decreased ATM activity and reduced 
phosphorylation of ATM substrates [59-61]. Changes in chromatin structure 
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can also activate ATM, even in the absence of DSBs, suggesting a model 
whereby altered chromatin structures lead to phosphorylation of Ser1981 of 
ATM in trans and dissociation of inactive ATM dimers into active monomers 
[54], however, defined ATM-dependent foci only arise at DSBs [54]. 
 
 
Figure 4: Role of ATM in cellular responses. ATM (ataxia-telangiectasia mutated) kinase 
activity increases immediately after the induction of DSBs following exposure to ionizing 
radiation. ATM mediates the early stages of the rapid induction of several signaling 
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pathways, which include regulation of the cell-cycle checkpoint controls, activation of the 
DSB repair pathways, activation of stress responses and maintenance of telomeres. Figure 
was taken from Tej K. Pandita, 2003 [57].  
 
2.1.3.2 -H2AX 
H2AX is one of a set of histone H2A variant proteins which constitutes 
2-25% of the mammalian histone H2A depending on the organism and cell 
type [62, 63]. In response to DSB induction, H2AX is rapidly phosphorylated 
at serine 129 in mouse (serine 139 in human) on its C–terminal tail at a 
conserved SQE motif by members of the PIKKs, including ATM, ATR and 
DNA-PKcs [20, 62]. ATM is the major kinase to phosphorylate histone H2AX 
under physiological conditions [20, 64]. Numerous H2AX are phosphorylated 
in chromatin regions flanking the lesion [65, 66], which can be easily detected 
by antibodies against -H2AX, leading to the formation of discrete nuclear 
foci visible in immunofluorescence microscopy. In our latest study, we have 
shown by transmission electron microscopic approach that -H2AX, as well as 
other repair factors forming RIF visualized by fluorescence microscopy, 
appeared exclusively in heterochromatin, which support the idea that these 
components may promote localized chromatin decondensation necessary for 
repair in more complex heterochromatin [67]. Discrete -H2AX foci appear 
within 3 minutes after irradiation [65], then grow in size and number and 
reach a plateau within 10 to 30 minutes after irradiation [66]. The level of the 
plateau is proportional to the radiation dose [62]. Once DSBs are repaired, the 
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-H2AX will be removed by two non-exclusive mechanisms: 
dephosphorylation of -H2AX by protein phosphatases [18] and removal of 
-H2AX from the chromatin through histone exchange with unphosphorylated 
H2AX from the nucleoplasm (and dephosphorylation after its displacement 
from chromatin) [68]. These processes persist until 2 to 24 hours following 
irradiation. It has been reported that the kinetics of -H2AX foci loss is related 
to the DSB repair capacity in somatic cells [69] and germ cells [70]. Persistent 
-H2AX foci after the initial induction of DNA damage indicate that some of 
the damage remains unrepaired. Because of its sensitivity and simplicity, 
detection of -H2AX has been widely used to monitor DNA damage, 
especially induced by IR in the low dose range, and subtle changes caused by 
radiation-induced bystander effects [71] or by genomic instability [72]. 
Co-localization of -H2AX foci with other proteins involved in DNA damage 
repair allows spatial and temporal dissection of these processes. However it 
should be noted that there is a variable background level of -H2AX signals 
primarily associated with DNA replication and expressed mostly in S-phase 
cells [73]. 
It is believed that H2AX phosphorylation stabilizes the interaction of DSB 
response proteins, such as 53BP-1 [74], BRCA1 and NBS1 at the repair site 
[75-77] and acts as an assembly platform to facilitate the accumulation of 
DNA damage response proteins onto damaged chromatin. These DNA 
repair-related proteins subsequently congregate at the -H2AX foci during the 
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repair process. Although their recruitment to DSBs is not completely 
dependent on H2AX phosphorylation, H2AX is an important element in 
proper damage response foci formation by enhancing the retention of repair 
factors after their initial recruitment [75]. The -H2AX binds directly to the 
BRCT repeat of MDC1 [78]. This complex formation regulates H2AX 
phosphorylation and is required accordingly for recruitment of DSB response 
proteins to flanking chromatin [18, 79, 80] and for normal radioresistance [78]. 
Cells lacking H2AX are able to undergo checkpoint activation and cell cycle 
arrest [76], but are unable to maintain arrest in the presence of persistent 
damage [81]. This defective G2/M checkpoint response is likely to be caused 
by the impaired accumulation of checkpoint factors such as MDC1, 53BP1 at 
DSBs, which serve as an amplification step at low levels of DNA damage. 
H2AX-/- mice have moderate defects including radiation sensitivity, growth 
retardation, male specific infertility and immunodeficiency which are 
consistent with deficiencies in DNA repair [76, 82]. 
 
2.1.3.3 53BP1 
The p53 binding protein 1 (53BP1), a protein identified through its ability 
to bind to p53, is initially proposed to function as a transcriptional coactivator 
of the tumor suppressor p53. It has two tandem C-terminal BRCT domains, 
which are present in a number of proteins involved in DNA damage signaling 
and DNA repair. BRCT domains are protein-protein interaction domains and 
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in 53BP1 they mediate its interaction with p53 [83, 84]. Unlike other p53 
binding proteins such as MDM2 and TBP [85, 86], which bind to the 
N-terminal transcriptional activation domain of p53, 53BP1 binds to the 
central domain of p53, a region responsible for sequence-specific DNA 
binding that is normally mutated in human tumors [87].  
53BP1 is found to be a nuclear protein that localizes rapidly to discrete 
foci following treatment with agents that cause DSBs, such as IR [88-90]. 
53BP1 foci are formed within five minutes after irradiation with doses as low 
as 0.5 Gy. The number of 53BP1 foci increases over time, reaching a 
maximum at about 15-30 minutes after irradiation [88] and then decreases 
rapidly in the first few hours after irradiation followed by a slower dispersing 
process at later time. The persistent foci exhibiting after 24 hours or later may 
be correlated with unrepaired or misrepaired DSB or alteration in the 
chromatin structure [91]. The maximum value of 53BP1 foci, about 20 foci 
per cell per Gy, closely parallels the number of DSBs. Furthermore, the 
kinetics of 53BP1 foci resolution appears to be very similar to the kinetics of 
DSB repair following IR. Therefore, 53BP1 foci may represent “sites of 
DSBs”, a hypothesis that is supported by the colocalization of 53BP1 foci 
with other foci known to mark sites of DSBs, such as -H2AX [62, 65, 88-90, 
92]. 
Radiation-induced 53BP1 foci occur in almost all cell cycle phases except 
those in mitosis [90]. In terms of the early response after IR, the specificity for 
Introduction 20 
agents inducing DSB, and the involvement of the entire population of 
irradiated cells, 53BP1 gains an advantage as a biomarker over lots of other 
proteins, such as MRE11, NBS1, RAD50, RAD51, RAD54, BLM and 
BRCA1 [92-94]. The mechanism of initial recruitment of 53BP1 is still 
unclear. Two observations suggest that 53BP1 might be a sensor of DSBs: first, 
53BP1 recruitment to sites of DSBs does not require ATM or other DNA 
damage checkpoint proteins; second, depletion of 53BP1 by siRNA leads to 
reduced ATM phosphorylation [88, 95]. A proposed hypothesis is that 
DSB-associated changes in chromatin structure increase the exposition of 
methylated histone tails facilitating initial recruitment of 53BP1. Subsequent 
phosphorylation of histone H2AX stabilizes the binding of 53BP1 to 
chromatin. Further recruitment of 53BP1 into focal structure is also a highly 
complicated process involving many regulatory steps and multiple 
posttranslational modifications of various proteins including phosphorylation 
of H2AX, recruitment of MDC1 and the E3 ubiquitin ligase-protein RNF8, 
methylation of histone H3 and H4, and Tip60 HAT activation [96]. Lack of 
interactions between these factors impairs the formation of 53BP1 foci. 
Knockout or knockdown of 53BP1 results in cell cycle checkpoint defects 
and genome instability which is typified by increased levels of chromatid gaps, 
breaks and exchanges. 53BP1-/- mice and cell lines exhibits an increased 
sensitivity to exogenous DNA damage, which indicates that 53BP1 is 
involved in DSB repair [74]. Evidence shows that 53BP1 Tudor domains are 
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able to stimulate the ligase activity of the DNA ligase IV/XRCC4 complex in 
vitro [97, 98], suggesting that there may exist a 53BP1-dependent pathway 
distinct from the core NHEJ pathway. In addition, 53BP1 was reported to 
contribute to the NHEJ repair by an ATM-Artemis-LigIV/XRCC4-dependent 
pathway, which is required in late repair kinetics in G1 phase [23, 52]. 
 
2.2 Low-dose radiation 
First of all, we should clarify what the definition of low-dose radiation as 
well as low dose-rate radiation means. The ICRP (International Commission 
on Radiological Protection) applied absorbed doses below 200 mGy and from 
higher absorbed doses when the dose rate is less than 100 mGy per hour as 
low-dose radiation and low dose-rate radiation. However, the NRPB (National 
Radiological Protection Board) conservatively adopted lower criteria than 
ICRP and the values may be more reasonable for practical purpose: low acute 
doses are those below 100 mGy and low dose-rates are those below 5 mGy 
per hour [99]. Although low-dose radiation has no immediately noticeable 
effects on organisms, it attracts great interest since it may have long-time 
biological effects on cancer induction in exposed individuals and genetic 
defects in their progeny. Various models have been developed to account for 
the features of radiation dose-response relationships. The no-threshold model 
means that there is no safe level, because all dose levels (regardless how small 
the radiation doses might be) are potentially harmful. The available biological 
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and biophysical data provide support for this linear no-threshold (LNT) risk 
model which postulates that the risk of cancer induction from radiation 
exposure is assumed to be proportional to the absorbed dose. Therefore, any 
exposure to radiation (above zero-dose), linearly increases the risk of radiation 
sickness, cancer or cell death, suggesting that no level of radiation is safe. 
Because of absence of direct data, the effects of low-dose radiation are 
currently estimated by extrapolating from the effects of high-dose radiation 
[100] which is by using the LNT model. However, recent findings in radiation 
and molecular biology strongly challenge this LNT concept in the low dose 
range. The biological mechanisms and responses are considerably more 
complex than predicted by that LNT model. Several new conceptions have 
been proposed, including hyper-radiosensitivity, untargeted effects and 
adaptive-response mechanisms. 
2.2.1 Hyper-radiosensitivity and increasing radioresistance 
Studies by Joiner et al. [101, 102] and Wouters et al. [103-105] revealed 
that many human tumor cell lines exhibit a low-dose hypersensitivity to 
radiation (termed HRS for hyper-radiosensitivity), which describes a 
phenomenon that cells die from excessive sensitivity to small single doses of 
ionizing radiation. This effect usually manifested at doses ＜0.5 Gy as a clear 
deviation from the standard linear-quadratic cell survival response, 
extrapolated from higher doses back to 0 Gy. It is accompanied by an increase 
in radioresistance at dose in the range of 0.5 Gy- 1 Gy (termed IRR for 
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increased radioresistance). By fitting cell survival data with Joiner’s Induced- 
Repair-model [101, 106], Brian et al. propose a more detailed description of 
the HRS/IRR phenomena: the mammalian cells exhibit hyper-radiosensitivity 
(HRS) to radiation doses of less than ~0.3 Gy when given at acute dose-rate, 
over the ~0.3 - 0.6 Gy dose range, a more radioresistant response per unit dose 
was evident, as illustrated by the shallower slope of the radiation 
dose–response curve [107]. At values greater than 1 Gy, a downward-bending 
survival curve was observed, that is well described by a linear quadratic 
expression [107]. The exact molecular mechanisms responsible for the 
HRS/IRR phenomena still remain unclear. Using the -H2AX assay, Wykes et 
al. [108] found no relationship between the initial or residual levels of DSBs 
and the prevalence of HRS, indicating that HRS does not reflect a failure of 
DNA break recognition. However, Simonsson et al. [107] reported a 
hypersensitive dose response pattern for the persistence of -H2AX foci in 
epidermal skin cells in patients biopsy samples 30 minutes after a 0.3 Gy 
therapeutic dose, indicating a tentative relationship with DSB repair and HRS. 
The most credence so far is that cellular repair processes elicited in response 
to radiation-induced damage overcome HRS and trigger IRR. The 
dose-dependent activation pattern for ATM activity would produce a 
changeover point in the low-dose range radiation, exactly as what has been 
demonstrated with the transition from HRS to IRR [54, 107, 109, 110], which 
indicates that the notable role of ATM in the differential effectiveness in 
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low-dose radiation. However, more data showed that ATM activation does not 
play a primary role in initiating radioresistance. Furthermore, a relationship 
was discovered between the function of the downstream ATM-dependent early 
G2-phase checkpoint and the prevalence and overcoming of HRS [111]. 
Consequently, the early G2-phase checkpoint was proposed as critical event 
controlling the transitional low-dose radiation exposure [112]. In the 
meanwhile, MRN complex, DNA-PK [113, 114] and PARP-1 [115, 116] have 
all been demonstrated for overcoming HRS and instigating IRR response, 
which are all involved in the major repair pathways of radiation-induced DSB. 
Although ATM activation alone is not the key determinant for overcoming 
HRS, apoptotic response mediated through the p53-dependent activation of 
Caspase 3, which is also a part of the signal cascade downstream of ATM 
activation, has been identified as important for HRS [117]. Therefore it 
appears that HRS might be a default mechanism to prevent potentially 
mutagenic G2 phase cells from entering mitosis [118]. Accordingly, it may be 
that HRS is not important for slowly proliferating normal tissues. As HRS has 
been strongly linked with the rapid progression of radiation-damaged 
G2-phase cells, therefore HRS is more likely to affect early-responding 




Figure 5: Typical cell survival curve with evidence of hyper-radiosensitivity (HRS). 
Figure was taken from Brian Marples, 2008 [107]. 
 
2.2.2 Untargeted effects  
Untargeted effects are responses observed in cells that were not subject to 
energy deposition events induced by ionizing radiation. These cells have 
received damaging signals produced by irradiated cells (radiation-induced 
bystander effect) or are the descendants of irradiated cells (radiation-induced 
genomic instability). Radiation-induced genomic instability is characterized 
by a number of delayed adverse responses including chromosomal 
abnormalities, gene mutations, and loss of reproductive potential and cell 
death, which is accepted as one of the most important aspects of 
carcinogenesis. Bystander effect can be exhibited in many ways, such as 
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damage-inducible stress response [119-122], sister chromatid exchange 
[123-125], micronucleus formation [126, 127], apoptosis [126], gene mutation 
[128-130] and chromosomal instability [131]. It can also be demonstrated as 
increased cell proliferation [132, 133], release of growth inhibitory factors 
[134] and radioresistance to subsequently challenge radiation dose [135, 136]. 
It seems that there are both damaging and protective cell signals that are 
encompassed within the general field of bystander effect. In the low-dose 
radiation range, bystander effect postulates that the effect may be even more 
complex than that predicted by the LNT model, since irradiated cells may 
signal their distress to the neighbors and initiate response in them. Such 
signals may be from direct cell-to-cell interaction via cell gap junctions or the 
molecules secreted by the irradiated cells to the medium. Some possible 
candidates for the signal are reactive oxygen, nitrogen species and various 
cytokines such as IL-8 [100, 137, 138]. Bystander effect is not a universal 
phenomenon, not all cells are able to produce bystander signals or respond to 
them, which depend on the genetic background of the cell, cell type, cell cycle 
phase and the property and dose of the radiation. In general, bystander effect 
appears to be a low-dose phenomenon [139]. Some in vitro studies have 
reported the effects could exhibit at gamma rays radiation dose as low as 2 




2.2.3 Adaptive response 
When cells were exposed to a very low dose of radiation, a priming dose, 
followed with a larger dose after a short time, the challenge dose, the 
frequency of chromosomal aberrations induced by the challenge dose was 
substantially reduced comparing with that from the challenge dose given alone 
[141, 142]. This has been termed the adaptive response. Adaptive response 
can be divided into three successive biological phenomena, the intracellular 
response, the extracellular signal and the maintenance. The intercellular 
response leading to adaptation of a single cell is a complex biological process 
including induction or suppression of gene groups. An extracellular signal, the 
nature of which is still unknown, may be sent by the affected cell to 
neighbouring cells causing them to adapt as well. Adaptive response can be 
maintained for periods ranging from of a few hours to several months, even 
the entire life span, which may be related with the constantly increased levels 
of ROS (reactive oxygen species) or NO (nitric oxide) in adaptive cells [143, 
144]. Radioadaptive responses have been observed in vitro and in vivo using 
indicators of cellular damage, such as cell lethality, chromosomal aberrations, 
mutation induction, radiosensitivity, and DNA repair [141, 145-149]. 
Adaptation has been shown in response to both low LET (X-rays, -rays, 
-particles) [150-152] and high LET (neutrons, particles) [149, 153] 
radiation and is known to show a high degree of inter- and intra-individual 
variability. The variability may depend on factors such as dose-rate [151], 
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time interval between the doses [154, 155], genetic variation among 
individuals [156, 157] and experimental conditions [158]. In general, in 
experimental set-ups resulting in adaptive behavior the values have been 
found to range from 0.01 to 0.5 Gy and from 0.01 to 1.0 Gy/min for priming 
dose and priming dose rate, respectively [159]. An interval of at least 4 hours 
is necessary between the priming dose and the challenge dose for the 
maximum adaptive radioresistance to be seen [150]. 
The adaptive response phenotype has been associated with an increase of 
cellular functions such as DNA repair and stress response. The activation of 
PARP (poly ADP-ribose polymerase), known to be involved in DNA repair 
and cellular ageing, is required for adaptation [155, 160]. Khodarev et al. 
found that STAT1, a component of the cytokine IFN signaling pathway, was 
significantly up-regulated during adaptation [161]. A study by Coleman et al. 
compared transcript profiles of human lymphoblastoid cell lines showing or 
not showing adaptive response and found that many of the genes up- or 
down-regulated in adapting cell lines could be associated with p53 functions 
[162]. In general, cell lines showing adaptive response showed induction of 
groups of genes associated with DNA repair and stress response while 





2.3 Early- and late-responding tissues in radiation 
Radiotherapy is an important curative and palliative modality in the 
treatment of cancer, but associated toxicities of neighbouring normal tissues 
remain the most important obstacle in delivering dose intensity. Radiotherapy 
toxicity is generally separated into acute toxicity and late toxicity. Acute 
toxicities (early responses) occurs during or shortly after the radiotherapy and 
usually arise in rapidly renewing tissues where a small number of stem cells 
divide slowly and regularly to provide a steady supply of proliferative 
progenitor cells which differentiate into mature, nonproliferative, functioning 
cells. The proliferative damage of radiation-vulnerable stem cells and 
progenitor cells causes a transient decrease in the number of specific 
functioning cells, but this acute toxicity heals by proliferation of surviving 
stem cells. Late toxicities (late responses) can manifest itself months to years 
after the completion of the treatment and usually arise in slowly renewing 
tissues composed of highly differentiated cell populations performing 
specialized functions, for example, the tubule epithelium in kidney, the 
cardiomyocytes in heart, the alveolar epithelium in lung and the 
oligodendroglia in brain. Only a low percentage of these functional cells 
maintain the capacity of proliferation on demand. In contrast to transient, 
clinically manageable acute responses, late normal tissue injury is often 
progressive with few therapeutic options and substantial long-term morbidity 
and mortality. 
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Kidneys, which are made up of millions of nephrons that act as individual 
filtering units, are the main and the most radiosensitive part of the urinary 
system which helps maintain homeostasis by removing metabolic waste from 
the blood and regulating fluid and electrolyte balance in the body. As 
dose-limiting organs for local radiotherapy involving upper abdomen and total 
body irradiation, radiation-induced kidney injury can manifest as benign or 
malignant hypertension, elevated creatinine levels, anemia, and renal failure, 
which can be lethal. The adult kidney is a slow-turnover tissue. Studies with 
tritiated thymidine have shown that both tubular and endothelial cells have 
low labeling indices of 0.4% and 0.1% [163], indicating that the normal 
turnover of these cells is slow. However, the kidney is capable of responding 
to injury, such as surgery, chemicals and irradiation, by transient increased 
proliferation [164, 165]. Irradiation can induce an early, dose related increase 
in proliferation in tubules [164] and this stimulated proliferation after 
irradiation can precede the onset of functional damage and persist for 6 to 12 
months [164]. But this proliferation is not associated with increased cell 
number, indicating that cell proliferation is matched by cell loss [166, 167]. 
Intestine is an important normal tissue at risk during the radiotherapy in 
the abdomen or pelvis. The absorptive epithelium of the small intestine, which 
is ordered into crypts and villi, constantly undergoes shedding and 
replenishment. These epithelial cells proliferate in the crypts, migrate along 
the villi, and then are eventually shed into the intestinal lumen. The cell cycle 
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time for the majority of proliferating cells in the mouse intestine crypt is in the 
order of 12-13 hours, whereas the cell cycle time for crypt stem cells is 
considerably longer at approximately 24 hours. The total transit time for cells 
from the crypt base to the villus tip is about 6-8 days and it takes 48-72 hours 
from when a cell enters the villus base until it is shed from its tip [168]. Acute 
radiation injury to the intestine manifests when cells in the differentiated 
cellular compartment in the villus are no longer adequately replaced by cells 
from the progenitor compartment in the crypt. Accelerated compensatory 
proliferation is initiated on this damage, when crypt cell cycle times may be as 
short as 6 hours [169-171]. 
 
2.4 Aim of this project 
Low dose irradiation is ubiquitous in our environment. The biological 
effect is more complicated than high dose irradiation which is estimated by 
the linear-quadratic (LQ) model (a model in which the effect is a 
linear-quadratic function of dose). Hyper-radiosensitivity, increasing 
radioresistance, untargeted effects, and adaptive effects are all involved to 
complicate the ultimate response to ionizing radiation. In the present study, we 
investigated the effects of fractionated low-dose radiation exposure on the 
accumulation of DSBs in normal tissues using an in vivo model with 
repair-proficient mice. This in vivo model may help us to estimate the effects 
of exposure to environmental and occupational sources of low-dose radiation 
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among the normal population; it may also help us to assess the long-term 
effects of normal tissue irradiation in the context of fractionated radiotherapy.
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3. Material and methods 
3.1 Animals 
8 week-old male C57BL/6 (wild-type, C57BL/6NCrl) mice of comparable 
weight were obtained from Charles River Laboratories (Sulzfeld, Germany). 
All mice were housed 6-7 per cage in laminar flow hoods under identically 
standard laboratory conditions (temperature 22±2 
0
C, 55 ±10 % humidity, and 
light-dark cycle 12:12), and had free access to sterilized laboratory food and 
water during the whole course of experiments. Before use, the mice were 
allowed to acclimatize from shipping for 1 week. All animal studies were 
performed according to the Institutional Animal Care and Use Guidelines, and 
the experimental protocol was approved by the Animal Care and Use 
committee of the Saarland University.   
 
3.2 Irradiation 
Whole body irradiation was performed in a special plastic cylinder with a 
6-MV linear accelerator at a dose rate of 2 Gy/min. The isodose distributions 
were evaluated by ADAC Pinnacle three-dimensional treatment planning 
system, revealing that the 95% isodose enclosed the whole body of each 
individual mouse.  
For the DSB induction, three mice were sacrificed at 30 min after a single 
dose radiation of 10 mGy or 100 mGy, respectively. For the fractionated 
low-dose radiation experiments, the mice were exposed to 10 mGy or 100 
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mGy, respectively, once every day from Monday to Friday, with time intervals 
of 24 hours between radiation exposures. After 2, 4, 6, 8, and 10 weeks of 
daily low-dose radiation, three mice were sacrificed at 24 or 72 hours after 
their last fraction. 
 
Figure 6: Fractionated irradiation schedule. 
 
3.3 Tissue sampling  
After anesthesia by an intraperitoneal injection of Xylazine (Rompun) and 
Ketamine (Rompun 1 ml and Ketamine 0.75 ml, diluted in 8.25 ml 0.9% 
natrium chloride solution, 0.1 ml/ 10 g), different organs (skin, heart, lung, 
liver, intestine, kidney, testis and brain) were quickly harvested. Each tissue 
was fixed in 4% neutral buffered formaldehyde 16h at room temperature. 
After dehydration with a graded series of ethanol and xyline by an automatic 
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tissue dehydration apparatus, the tissues were imbedded in paraffin and then 
cut into sections at an average thickness of 4 m. 
 
3.4 Immunofluorescence staining  
To analyze the residual DSBs in differentiated cells of kidney and intestine, 
we performed the immunofluorescence staining with antibodies against 
53BP1 according to the following protocols: 
Paraffin sections were dewaxed three times in 100% xyline (7 min each), 
and hydrated by graded dilute ethanol series: 100% ethanol, 96% ethanol, 
90% ethanol, 80% ethanol, 70% ethanol and distilled water (5 min each), 
followed by boiling in the citrate buffer (Dako REAL Target Retrieval 
Solution, #S-2031, pH 6.0) for 60 min at 96
0
C to unmask the antigenic sites. 
After 10 min natural cooling, sections were incubated at room temperature for 
1 hour with Roti-ImmunoBlock (T144.1, ROTH) to impede the non-specific 
interaction whilst preserve specific binding signals, reducing background and 
false-positive signals. Afterwards, the tissue sections were incubated with the 
primary rabbit polyclonal antibody against 53BP1 (Bethyl Laboratories, 
Cat.-No.IHC-00001, USA) at a dilution of 1:200 in a humidified chamber 
overnight at 4
0
C, then incubated with Alexa Fluor 488-conjugated goat-anti 
rabbit LgG (Invitrogen, Cat.-No.A11034, Germany) as secondary antibody at 
1:400 dilution in a humidified chamber for 60 min in dark at room 
temperature. Finally the sections were mounted by using DAPI-containing 
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mounting medium (VECTASHIELD Hard-set mounting medium, Vector 
Laboratories, Cat.-No.H-1400, USA) and stored overnight at 4
0
C before use. 
Between each step of incubation and mounting, the sections were gently 
washed with PBS three times (10 min each) on a shaker. 
 
3.5 Quantification of radiation-induced foci 
Sections were examined by using Nikon E600 epifluorescent microscope 
equipped with charge-coupled-device camera and acquisition software (Nikon, 
Düsseldorf, Germany). For quantitative analysis, the foci were scored in a 
blinded manner to avoid bias and counted by eye under ×600 or ×1000 
microscope magnification. For each data point, the kidney and intestine 
sections from three different mice were analyzed and the mean value was 
calculated. Counting was performed until at least 40 foci and 40 cells were 
registered for each sample. The error bars represented the SEM from the 
number of cells analyzed. 
 
3.6 Statistical analysis 
To evaluate the potential differences in residual DSB of normal tissue cells 
at different time point, the Mann-Whitney U test was performed. The criterion 
for the statistical signification was p≤0.05. 
Results 37 
4. Results 
4.1 DSB induction at low dose irradiation 
To investigate the induction of DSB in kidney and intestine after 
fractionated low dose irradiation, we performed 53BP1 immunofluorescence 
staining in the kidney and intestine sections. As described previously, 
well-defined regions encompassing the characteristic cell populations of the 
tissues were chosen for the quantitative 53BP1 foci analysis. In the kidney, the 
renal tubular epithelial cells in the renal cortex with the glomeruli and 
proximal and convoluted tubules were analyzed. In the small intestine, the 
enumerating of 53BP1 foci was confined to the epithelial cells of the mucosal 
surface forming the middle part of the villi, in order to exclude the disturbance 
of proliferating precursor cells in the crypts and the senescent cells at the top 
of the villi.  
As shown in Figure 7, the nuclei were uniformly stained with DAPI. In the 
background of diffuse 53BP1 staining, obvious discrete foci could be seen and 
the number of foci slightly increased in both kidney and intestine sections 
after irradiation, while the sham irradiated controls were predominantly 
negative for 53BP1 staining. The foci exhibited different characteristics; some 
were big and bright while some were small and dim. 
Results 38 




   
 
 
Figure 7: Immunofluorescence staining of 53BP1 (green foci) in kidney and intestine at 
24h after 30 and 50 fractions of 100 mGy, respectively, compared to unirradiated control 
tissues. 
 
In unirradiated normal tissue, we observed a low background level of foci 
with 0.07-0.11 foci per cell. At 30 min after a single dose irradiation with   
10 mGy or 100 mGy, both kinds of tissues exhibited nearly the same value of 
foci, with 0.2 foci per cell after 10 mGy and 1.3 foci per cell after 100 mGy. 
After subtraction of background level, 10 mGy induced 0.11 foci per cell and 
100 mGy induced 1.21 foci per cell. In our previous study, we have used 
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-H2AX foci to analyze the induction and repair of DSBs in mouse tissues 
after relative high doses and suggested a linear dose correlation for the 
induction of -H2AX foci from 0.1 Gy - 1 Gy in all analyzed mouse tissues. 
The induction of DSBs was 8 foci /cell /Gy measured 10 min after irradiation, 
with the background level of 0.04 foci per cell. As 53BP1 foci were supposed 
to colocalize with -H2AX foci in these tissues, present data were slightly 
higher than previous results, partly due to differences in sample staining and 





Figure 8: DSB induction quantified 
by enumerating 53BP1 foci in kidney 
and intestine at 30 min after 10 mGy or 
100 mGy irradiation. Error bars 




4.2 Residual foci in kidney 
In our previous study, we have assessed the formation and rejoining of 
DSBs in various normal tissues after fractionated irradiation in clinic relevant 
scheme [172]. Here, we evaluated the effects of fractionated low-dose 














at defined time points. As shown in Figure 8, the foci per cell did not vary 
obviously as dose increased in kidney. After fractionated low-dose radiation 
with 10 mGy, the average number of foci per cell in kidney fluctuated 
between 0.15 and 0.19 foci/cell at 24 hours and between 0.11 to 0.18 foci/cell 
at 72 hours after the last fraction. In the 100 mGy per fraction group, the foci 
per cell in kidney ranged between 0.27 and 0.38 foci/cell at 24hours after the 
last fraction, and decreased to 0.23 to 0.31 foci/cell at 72 hours after the last 
fraction. 
In the 10 mGy per fraction group, nearly identical foci levels at the 
different time points during irradiation, although the residual foci at 72 hours 
after the last fraction varied obviously compared to the values at 24 hours. In 
the 100 mGy per fraction group, slightly elevated, but consistent foci levels 
could be observed during irradiation. The residual foci at 72 hours peaked at 
50 fractions (cumulative dose 5 Gy) and the value at 24 hours peaked at 20 
fractions (cumulative dose 2 Gy) in this group. 
The values of foci per cell in the group of 100 mGy per fraction were 
constantly higher than that in the corresponding 10 mGy per fraction group. 
The residual foci levels at 24 hours after last fraction were higher than the 


































Figure 9: Residual 53BP1 foci per cell in tubular epithelial cells in kidney at 24 and 72 
hours after the last exposure to fractionated irradiation (10x, 20x, 30x, 40x, 50x) with 10 mGy 
and 100 mGy, respectively, compared to single dose irradiation (10 mGy, 100 mGy) and 




4.3 Residual foci in intestine 
To investigate the effect in the typical early-responding tissue during 
fractionated low-dose irradiation, we next analyzed small intestine tissues at 
defined time points. As Figure 10 showed, in the 10 mGy per fraction group, 
the average number of foci per cell fluctuated between 0.07 and 0.11 foci/cell 
at 24 hours and between 0.07 and 0.11 foci/cell at 72 hours after irradiation. 
When 100 mGy was given per fraction, the foci per cell ranged between 0.09 
and 0.16 foci/cell at 24 hours post irradiation and decreased between 0.06 and 
0.16 foci/cell at 72 hours post irradiation. In the 10 mGy per fraction group, 
residual foci varied very slightly, with no obvious minimum and maximum. In 
the 100 mGy per fraction group, by contrast, we observed low levels of 
residual foci after 10 fractions (cumulative dose 1 Gy) but clearly higher foci 
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levels after 40 fractions (cumulative dose 4 Gy) and 50 fractions (cumulative 
dose 5 Gy), respectively. 
In contrast to kidney, the values of foci per cell in the group of 100 mGy 
per fraction were not always higher than those of the corresponding 10 mGy 






























Figure 10: Residual 53BP1 foci per cell in the epithelial cells in intestine at 24 and 72 
hours after the last exposure to fractionated irradiation (10x, 20x, 30x, 40x, 50x) with 10 mGy 
and 100 mGy, respectively, compared to single dose irradiation (10 mGy, 100 mGy) and 
unirradiated control tissues. Error bars represent standard error of mean values from three 
samples. 
 
4.4 DSB repair in different organs 
The values of persistent foci in the tubular cells in kidney were always 
higher than those in the small intestine, independent of the dose per fraction, 
or analyzed time points, which reflect a lower efficiency in dealing with 
persistent foci. In previous studies our study group observed nearly identical 
DSB rejoining kinetics in differentiated somatic tissue cells after single-dose 
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irradiation with 2 Gy [172]. However, in these fractionated low dose 
irradiation experiments, we observed some differences regarding persistent 
foci levels between early- and late-responding tissues, which might be related 
to the ability to deal with complex DSBs or chromatin disruptions induced by 






























Figure 11: Residual 53BP1 foci per cell in tubular epithelial cells in kidney and in the 
epithelial cells in intestine at 24 hours after the last exposure to fractionated irradiation (10x, 
20x, 30x, 40x, 50x) with 10 mGy and 100 mGy, respectively, compared to single dose 
irradiation (10 mGy, 100 mGy) and unirradiated control tissues. Error bars represent 


























Figure 12: Residual 53BP1 foci per cell in tubular epithelial cells in kidney and in the 
epithelial cells in intestine at 72 hours after the last exposure to fractionated irradiation (10x, 
20x, 30x, 40x, 50x) with 10 mGy and 100 mGy, respectively, compared to single dose 
irradiation (10 mGy, 100 mGy) and unirradiated control tissues. Error bars represent 
standard error of mean values from three samples.
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5. Discussion 
Low dose radiation continues to be of great interests because of its 
potential dangers posed by exposure to environmental and occupational 
sources of radiation and because of the potential clinical benefits of 
radiotherapy. But the estimate of its biological effects has always been 
controversial due to no enough available evidences. In our present study, we 
established an in vivo model with repair –proficient mice to investigate the 
effects of fractionated low-dose radiation exposure on the accumulation of 
DSBs in normal tissues with different radiation characteristics. We found that 
a single acute low dose irradiation with 10 mGy or 100 mGy induced nearly 
the identical foci level in kidney and small intestine, which are the typical 
late- and early-responding tissues in radiation. In both kidney and small 
intestine, persistent foci levels at different time points varied slightly during 
fractionated irradiation with 10 mGy while slightly elevated, but consistent 
foci levels could be observed during fractionated irradiation with 100 mGy. 
However, the values of persistent foci in the tubular cells in kidney were 
always higher than those in the small intestine, independent of the dose per 
fraction, or analyzed time points, which may reflect a lower efficiency in 
dealing with persistent foci. 
 
5.1 RIF approach analysis in vivo 
In the present study, we used 53BP1 immunofluorescence assay to assess 
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the persistent DSBs in typical early- and late-responding tissues with 
repair-proficient murine model after fractionated low dose irradiation. 
Traditional methods for quantification of DSBs in cells were based on the 
separation of DNA molecules according to their size by gel electrophoresis 
techniques, including pulse-field gel electrophoresis (PFGE) [173, 174], 
which is considered as the gold standard to detect DSBs. These physical 
methods of DSB quantification are not especially sensitive, typically requiring 
the use of doses above 5 Gy for a reliable assessment for the rejoining kinetics, 
which exclude their utilization in evaluating the effects of low dose radiation 
and detecting persistent and subtle DSBs after radiation. Enumerating foci 
with microscopy has been identified to assess the induction and repair of 
DSBs based on the close correlation between foci level and DSBs numbers 
and between the rate of foci loss and DSBs repair, providing a sensitive assay 
to monitor DSB in individual cells using physiological doses [91, 175, 176]. 
Despite of all the advantages of this RIF approach, recent studies have 
suggested that some foci do not represent unrepaired DSBs and foci formation 
and dispersion may not follow the actual fate of the physical breaks but rather 
registers accompanying chromatin modifications [177, 178]. Furthermore, in 
our latest findings gained by transmission electron microscopy (TEM) 
analysis [67], we have revealed this RIF approach does not possess the 
sensitivity to detect all unrepaired DSBs. We have confirmed that the repair 
factors forming RIF are not evenly distributed throughout the entire nucleus 
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but exclusively allocated in the heterochromatic domains. Additionally, the 
RIF were in a great dimension (up to a diameter of 1 m), clustering over time 
and overlapping in the space. All these factors above may lead to the 
underestimation of unrepaired DSBs. However, this foci-approach is still 
widely used as a valuable indirect monitor of DSBs because of its sensitivity 
and simplicity, with more careful consideration in analyzing the obtained data. 
 
5.2 Residual foci in tissues with different radiation characteristics 
Pogribny et al. have confirmed that fractioned whole body low-dose 
radiation exposure resulted in a significant decrease in global DNA 
methylation and led to the accumulation and/or persistence of DNA damage as 
monitored by-H2AX foci in the murine thymus [179]. But no more data are 
available about its biological effect in complex normal tissues during the 
course of clinically relevant fractionation schedules. In the present study, we 
analyzed the residual DSBs measured by enumerating 53BP1 foci with 
different fractionated dose size and overall radiation dose in a clinical 
schedule in two other tissues: kidney and intestine, which are the two most 
involved organs when abdomen is irradiated and often become dose-limiting 
organs for radiotherapy of the upper abdomen, which may help us predict the 
injury of them in a new model other than LQ model. 
As we quantified the foci microscopically by eye, we didn’t get more 
exact information about the shape, size or intensity of the foci. Belyaev et al. 
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have previously reported that residual foci induced by low LET were 
significantly larger in size than the initial RIF [180, 181] and proposed that 
initial RIF are formed at the sites of DSB induction and cover megabase-size 
of chromatin domains at places of actual DSB localizations. Fast repair occurs 
in the initial foci usually 1-30 min after irradiation. Complex foci may require 
longer time periods to be repaired, some complex DSBs move along with 
corresponding chromatin domains/foci to produce clustering of the initial foci, 
which result into secondary larger foci representing sites for formation of 
chromosomal exchanges. In the present study, comparing the foci visible at 
30min after acute low dose irradiation, the sizes of foci in the tissue of kidney 
and intestine revealed no visible differences, respectively. However the 
majority of foci in the epithelia cells in intestine and tubular cells in kidney 
are smaller than those induced by relative high doses. 
The induction of foci measured 30 min after low dose irradiation were a 
little bit higher than our previous result, but they still demonstrate that low 
dose irradiation induce identical foci numbers in different normal tissues, 
regardless of their clinical characteristics. This result was in consistence with 
what Grudzenski and his colleagues have reported [182].  
The precise role of residual RIF that persist 24 hours and longer in cells is 
presently unknown, its possible links to chromatin alterations, delayed repair 
and misrepaired of DSB, apoptosis, activity of several kinases and 
phosphatases, and checkpoint signaling have been suggested [180, 183-185]. 
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Rothkamm et al. have previously reported that some residual 53BP1 and 
-H2AX foci remain in cells for a relative long time (≥ 24h) after irradiation 
and suggested possible correlation between cellular radiosensitivity and the 
numbers of residual foci [176]. However, no clear correlation has been 
established until now. Kidney and small intestine typically exhibit different 
radiosensitivity in clinic radiotherapy.  In our present study, we estimate the 
persistent foci level in these two tissues. As the figures showed previously, the 
values of persistent foci in the tubular cells in kidney were always higher than 
those in the small intestine, independent of the dose per fraction, or analyzed 
time points. This might be related to their ability to deal with complex DSBs 
and the alteration in chromatin induced by low dose irradiation. However, we 
should also consider that kidney is a slowly turn-over organ; the majority of 
the tubular cells are quiescent. Despite the radiation has the potential to 
stimulate proliferation in tubules, considering the efficiency of this stimulation 
and the small dose given, the cells still retain and have enough time to 
accumulate all the damages. On the contrast, the small intestine is a rapidly 
proliferating tissue. The cells lining the villi would turn over nearly every 6-8 
days. Accordingly, at a single cell level, the dose it has received is much lower 
than the accumulative dose we have given. 
As Grudzenski et al. demonstrated [182], foci were lost much less 
efficiently following a single 10 mGy dose comparing to the 100 mGy dose, 
with 5% unrepaired foci after 24 hours after a dose of 100 mGy but more than 
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50% of the initial induced foci persisted for up to 24 hours after 10 mGy, 
indicating that cells exhibited different repair efficiency after 10 mGy and 100 
mGy irradiation. Additionally, unrepaired DSBs accumulated in the 
fractionated irradiation course. As previously stated, increasing 
radioresistance, untargeted effects and adaptive response all had their 
thresholds and transition points, respectively, that means they would only 
trigger when the cumulative dose or damage reach some level, and these level 
may vary in different cell types or tissues. Hyper-radiosensitivity was 
exhibited in the range less than ~0.3 Gy, and the intervals between fractions 
which allowed recovery was another factor. Marples and Joiner [186] have 
shown that 6-24 hours were necessary between fractions to allow for recovery 
of HRS in V79 cells. Short et al. also suggested that when consecutive low 
doses were given, a lower than predicted cell survival, consistent with 
repeated HRS, only occurred when the doses were spaced by certain intervals 
[187]. At the molecular level, the trigger dose and recovery time for a 
particular molecule, such as ATM, early G2-phase checkpoint, and so on, 
remain unknown in complex physical environment, which have been revealed 
to be important in what way the cells decide to response to low dose 
irradiation. All of these different effects, depending on the fractionated dose 
size, accumulative dose, time left for repair, tissue characteristics etc, may 
explain that the foci levels reach their minimum and maximum value at 
different time points in kidney and intestine.
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